Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23702928)

1.

Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Cheung NK, Dyer MA.

Nat Rev Cancer. 2013 Jun;13(6):397-411. doi: 10.1038/nrc3526. Review.

2.

Neuroblastoma progress on many fronts: the Neuroblastoma Research Symposium.

Wylie L, Philpott A.

Pediatr Blood Cancer. 2012 Apr;58(4):649-51. doi: 10.1002/pbc.23329. Epub 2011 Sep 15.

3.

New insights into the genetics of neuroblastoma.

Sridhar S, Al-Moallem B, Kamal H, Terrile M, Stallings RL.

Mol Diagn Ther. 2013 Apr;17(2):63-9. doi: 10.1007/s40291-013-0019-6. Review.

PMID:
23329364
4.

Promising therapeutic targets in neuroblastoma.

Matthay KK, George RE, Yu AL.

Clin Cancer Res. 2012 May 15;18(10):2740-53. doi: 10.1158/1078-0432.CCR-11-1939. Review.

5.

New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK.

Barone G, Anderson J, Pearson AD, Petrie K, Chesler L.

Clin Cancer Res. 2013 Nov 1;19(21):5814-21. doi: 10.1158/1078-0432.CCR-13-0680. Epub 2013 Aug 21. Review.

6.

Immune therapies for neuroblastoma.

Navid F, Armstrong M, Barfield RC.

Cancer Biol Ther. 2009 May;8(10):874-82. Epub 2009 May 9. Review.

7.

The connections between neural crest development and neuroblastoma.

Jiang M, Stanke J, Lahti JM.

Curr Top Dev Biol. 2011;94:77-127. doi: 10.1016/B978-0-12-380916-2.00004-8. Review.

8.

MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.

Schulte JH, Lindner S, Bohrer A, Maurer J, De Preter K, Lefever S, Heukamp L, Schulte S, Molenaar J, Versteeg R, Thor T, Künkele A, Vandesompele J, Speleman F, Schorle H, Eggert A, Schramm A.

Oncogene. 2013 Feb 21;32(8):1059-65. doi: 10.1038/onc.2012.106. Epub 2012 Apr 9.

PMID:
22484425
9.

Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma.

Carpenter EL, Haglund EA, Mace EM, Deng D, Martinez D, Wood AC, Chow AK, Weiser DA, Belcastro LT, Winter C, Bresler SC, Vigny M, Mazot P, Asgharzadeh S, Seeger RC, Zhao H, Guo R, Christensen JG, Orange JS, Pawel BR, Lemmon MA, Mossé YP.

Oncogene. 2012 Nov 15;31(46):4859-67. doi: 10.1038/onc.2011.647. Epub 2012 Jan 23. Erratum in: Oncogene. 2012 Nov 15;31(46):4888. Vigny, M [added]; Mazot, P [added].

10.

Immunotherapy of neuroblastoma: present, past and future.

Raffaghello L, Pistoia V.

Expert Rev Neurother. 2006 Apr;6(4):509-18. Review.

PMID:
16623650
11.

Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.

Schönherr C, Ruuth K, Kamaraj S, Wang CL, Yang HL, Combaret V, Djos A, Martinsson T, Christensen JG, Palmer RH, Hallberg B.

Oncogene. 2012 Dec 13;31(50):5193-200. doi: 10.1038/onc.2012.12. Epub 2012 Jan 30.

PMID:
22286764
12.

Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model.

Nakagawara A, Ohira M.

Cancer Lett. 2004 Feb 20;204(2):213-24. Review.

PMID:
15013220
13.

Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.

Owens C, Irwin M.

Crit Rev Clin Lab Sci. 2012 May-Jun;49(3):85-115. doi: 10.3109/10408363.2012.683483. Review.

PMID:
22646747
14.

Development of the peripheral sympathetic nervous system in zebrafish.

Stewart RA, Look AT, Kanki JP, Henion PD.

Methods Cell Biol. 2004;76:237-60. No abstract available.

PMID:
15602879
15.

[Recent advances in neuroblastoma research].

Imaizumi M.

Seikagaku. 2004 May;76(5):453-6. Review. Japanese. No abstract available.

PMID:
15212235
16.

[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].

Pérel Y, Valteau-Couanet D, Michon J, Lavrand F, Coze C, Bergeron C, Notz A, Plantaz D, Chastagner P, Bernard F, Thomas C, Rubie H.

Arch Pediatr. 2004 Jul;11(7):834-42. Review. French.

PMID:
15234382
17.

Genome and transcriptome analysis of neuroblastoma advanced diagnosis from innovative therapies.

Coco S, Tonini GP, Stigliani S, Scaruffi P.

Curr Pharm Des. 2009;15(4):448-55. Review.

PMID:
19199972
18.

Therapeutic strategies for the treatment of neuroblastoma.

Izbicka E, Izbicki T.

Curr Opin Investig Drugs. 2005 Dec;6(12):1200-14. Review.

PMID:
16370386
19.

New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.

Zage PE, Louis CU, Cohn SL.

Pediatr Blood Cancer. 2012 Jul 1;58(7):1099-105. doi: 10.1002/pbc.24116. Epub 2012 Feb 29. Review.

20.

Molecularly guided therapy of neuroblastoma: a review of different approaches.

Tonini GP, Pistoia V.

Curr Pharm Des. 2006;12(18):2303-17. Review.

PMID:
16787256
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk